3-year Follow-up of Patients with Stress Urinary Incontinence treated with minimally invasive Er:YAG laser
IUGA Academy. Gaspar A. Jun 30, 2018; 213015; 293 Topic: Stress Incontinence
Prof. Dr. Adrian Gaspar
Prof. Dr. Adrian Gaspar

Access to Premium content is currently a membership benefit.

Click here to join IUGA or renew your membership.

Discussion Forum (0)
Rate & Comment (0)


3-year follow-up of patients with stress urinary incontinence treated with minimally invasive Er:YAG laser

Gaspar, A1

1: Uroclinic Mendoza Argentina

Introduction: Stress urinary incontinence (SUI) is a common health problem that affects roughly 35 % of women in the reproductive period and can greatly affect the quality of life.
Aim: A controlled study was conducted to assess the long-term efficacy of sub-ablative Er:YAG laser treatment of SUI. The effects were compared to the effects of Pelvic Floor Muscle Training (PFMT), known as first line treatment method for mild and moderate SUI.
Methods: Altogether 72 women participated in our study, 29 women were included in PFMT group and 49 women underwent the non-ablative Er:YAG laser vaginal procedure. 1-h pad test, 24-h pad test, 3-day voiding diary and ICIQ-UI SF questionnaires were used to assess the effect of each treatment modality at the beginning and at multiple follow-up appointments (3-, 6-, 12-, 18-, 24-, 30- and 36-months) following the treatment. Patients were questioned about discomfort during treatment and any adverse events following the procedure.
Results: All outcome measures in laser group show statistically significant improvement over time of 12 months following initial laser treatment. The improvement rates in laser group were significantly higher than in PFMT group. 18-months follow-up appointment revealed a fading of the effect that was alleviated by additional maintenance treatments. These were performed at 18-, 24- and 30-months follow-up appointment. The overall improvement after 36 months determined by ICIQ-SF UI, 1-h pad test and 3-d voiding diary (average leakage frequency) was 93 %, 45 % and 70 %, respectively. There were no serious adverse events during our study; all patients reported a mild discomfort during laser procedure and 9 % of patients reported on de novo urge incontinence that resolved within 7 days.
Conclusions: The application of non-ablative Er:YAG vaginal laser for SUI treatment significantly improves the condition, and its effects can last up to 12 months. High rates of improvement of QoL are achieved if maintenance


Work supported by industry: no.

Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings